Ben Hirschler and Ludwig Burger, REUTERS (REUTERS) — Bayer will move a heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular treatments after the experimental medicine showed a “striking” reduction in deaths in a mid-stage trial. Having done well with recently launched drugs such as stroke prevention pill Xarelto and eye […]
